Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

ClinicalTrials.gov ID: NCT05151731

Public ClinicalTrials.gov record NCT05151731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Multicenter, Randomized, Double Masked, Active Comparator-Controlled Study to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients With Diabetic Macular Edema

Study identification

NCT ID
NCT05151731
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
394 participants

Conditions and interventions

Interventions

  • Ranibizumab Drug
  • Sham Procedure Other
  • Vamikibart Drug

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 30, 2021
Primary completion
Nov 5, 2024
Completion
Apr 20, 2025
Last update posted
May 10, 2026

2021 – 2025

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Win Retina Arcadia California 91006
Retina Consultants, San Diego Poway California 92064
Retinal Consultants Med Group Sacramento California 95825
Bay Area Retina Associates Walnut Creek California 94598
Colorado Retina Associates, PC Lakewood Colorado 80228
Emerson Clinical Research Institute LLC Washington D.C. District of Columbia 20011-3010
Rand Eye Deerfield Beach Florida 33064
National Ophthalmic Research Institute Fort Myers Florida 33912
Florida Retina Institute Orlando Florida 32806-1101
Retina Vitreous Associates of Florida St. Petersburg Florida 33607
Retina Specialists of Tampa Wesley Chapel Florida 33544
Butchertown Clinical Trials Louisville Kentucky 40206
Cumberland Valley Retina PC Hagerstown Maryland 21740
Deep Blue Retina PLLC Southaven Mississippi 38671
Sierra Eye Associates Reno Nevada 89502
Opthalmic Consultants of LI Lynbrook New York 11563
University of Rochester Flaum Eye Institute Rochester New York 14642
Western Carolina Retinal Associate PA Asheville North Carolina 28803
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157
Meridian Clinical Research Cincinnati Ohio 45219
Verum Research LLC Eugene Oregon 97401
EyeHealth Northwest Portland Oregon 97225
Erie Retinal Surgery Erie Pennsylvania 16507
Eye Care Specialists, PC Kingston Pennsylvania 18704
Sewickley Eye Group Sewickley Pennsylvania 15143
Charleston Neuroscience Institute Ladson South Carolina 29456
Black Hills Eye Institute Rapid City South Dakota 57701
Retina Consultants of Nashville Nashville Tennessee 37203
Texas Retina Associates Arlington Texas 75075
Austin Clinical Research LLC Austin Texas 78750
Retina Consultants of Texas Bellaire Texas 77401
Valley Retina Institute P.A. McAllen Texas 78503
Retina Consultants of Texas The Woodlands Texas 78240
Strategic Clinical Research Group, LLC Willow Park Texas 76087
Piedmont Eye Center Lynchburg Virginia 24502
Wagner Macula & Retina Center Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05151731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2026 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05151731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →